Drugs / Sm-153
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00365105 | Jul 2006 → Jan 2012 | breast cancer, lung cancer, metastatic malignant neoplasm, prostate cancer | Radiation Therapy Oncology Group | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sm-153 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00365105 ↗ |
| Route | Intravenous | “Single dose intravenously 1 mCi/kg body weight” NCT00365105 ↗ |